Meta-analysis of probiotics and/or prebiotics for the prevention of eczema (Q45213834)

10 December 2017

0 references

Meta-analysis of probiotics and/or prebiotics for the prevention of eczema (English)

1 reference

10 December 2017

0 references

Dan Dang

1

1 reference

10 December 2017

Wenli Zhou

2

1 reference

10 December 2017

Zhi Jun Lun

3

1 reference

10 December 2017

Xin Mu

4

1 reference

10 December 2017

Dong Xuan Wang

5

1 reference

10 December 2017

Hui Wu

6

1 reference

10 December 2017

1 August 2013

1 reference

Journal of International Medical Research

10 December 2017

1 reference

10 December 2017

41

1 reference

10 December 2017

5

1 reference

10 December 2017

1426-1436

1 reference

The hygiene hypothesis revisited

10 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Is eczema really on the increase worldwide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Development of allergen-specific T-cell memory in atopic and normal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Low diversity of the gut microbiota in infants with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

21 January 2018

Probiotics in surgery

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Probiotics during weaning reduce the incidence of eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

The effects of selected probiotic strains on the development of eczema (the PandA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Probiotic supplementation in the first 6 months of life in at risk Asian infants - effects on eczema and atopic sensitization at the age of 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Probiotic effects on T-cell maturation in infants during weaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Asthma in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513493692

21 January 2018

Identifiers

DOI

10.1177/0300060513493692

1 reference

10 December 2017

1 reference